{"id":4281,"date":"2023-05-25T08:29:06","date_gmt":"2023-05-25T00:29:06","guid":{"rendered":"https:\/\/regask.com\/?p=4281"},"modified":"2024-10-26T02:58:11","modified_gmt":"2024-10-25T18:58:11","slug":"italien-dokument-zur-qualitatssicherung-klinischer-studien","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/italy-clinical-trials-qa-document\/","title":{"rendered":"Italien ver\u00f6ffentlicht Neuigkeiten zum Frage-und-Antwort-Dokument zu klinischen \u2026"},"content":{"rendered":"<div>\n<div>Der <a href=\"https:\/\/www.aifa.gov.it\/en\/\" target=\"_blank\" rel=\"noopener\">Italienische Arzneimittelagentur (AIFA)<\/a> K\u00fcrzlich wurden Neuigkeiten zu einem neuen Dokument \u201eFragen und Antworten Version 1.0\u201c ver\u00f6ffentlicht. Ziel ist es, die Umsetzung neuer Vorschriften f\u00fcr klinische Studien zu erleichtern.<\/div>\n<div><\/div>\n<div>Dieses Dokument enth\u00e4lt die bereits auf der AIFA-Website ver\u00f6ffentlichten Fragen und Antworten, gruppiert nach Typ, mit Aktualisierungen und neuen Fragen und Antworten. Das Dokument wird von der AIFA fortlaufend aktualisiert. Die Fragen und Antworten beziehen sich speziell auf Italien und beziehen sich auf Fragen, die in den von der Europ\u00e4ischen Kommission ver\u00f6ffentlichten Dokumenten noch nicht enthalten sind.<\/div>\n<div><\/div>\n<\/div>\n<ul>\n<li><strong>Lesen Sie mehr dar\u00fcber, wie das RegASK DCT-Handbuch helfen kann:\u00a0<\/strong><strong><a href=\"https:\/\/regask.com\/de\/regulatory-guidebooks-paved-the-way-for-decentralized-clinical-trials\/\" target=\"_blank\" rel=\"noopener\">Regulatorische Leitf\u00e4den ebneten den Weg f\u00fcr dezentrale klinische Studien<\/a><\/strong><\/li>\n<li>M\u00f6chten Sie mehr \u00fcber \u00c4nderungen der DCT-Regelung erfahren? <a href=\"https:\/\/regask.com\/de\/kontakt\/\" target=\"_blank\" rel=\"noopener\">Nehmen Sie Kontakt mit den Experten von RegASK auf.<\/a><\/li>\n<\/ul>\n<div><\/div>\n<a href=\"https:\/\/regask.com\/de\/kontakt\/\" class=\"button secondary\" style=\"border-radius:10px;\">\n\t\t<span>Kontaktieren Sie RegASK f\u00fcr weitere Details<\/span>\n\t<\/a>\n\n<a href=\"https:\/\/regask.com\/de\/kategorie\/neuesten-erkenntnisse\/medical-devices-latest-insights\/\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>Mehr lesen<\/span>\n\t<\/a>\n\n<div class=\"row\"  id=\"row-1488751324\">\n\n\t<div id=\"col-80302319\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<a href=\"https:\/\/regask.com\/de\/fallstudien\/ressourcen-fallstudien-medizinprodukte\/\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>Lesen Sie Fallstudien aus der Medizinger\u00e4tebranche<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Die italienische Arzneimittelbeh\u00f6rde (AIFA) hat k\u00fcrzlich ein neues Dokument mit dem Titel \u2018Fragen &amp; Antworten Version 1.0\u2019 ver\u00f6ffentlicht. Dieses Dokument soll die Umsetzung der neuen Richtlinien f\u00fcr klinische Pr\u00fcfungen erleichtern. Es fasst die bereits auf der Website der AIFA ver\u00f6ffentlichten Fragen und Antworten zusammen, gruppiert sie nach Themenbereichen und enth\u00e4lt Aktualisierungen sowie neue Fragen und Antworten.<\/p>","protected":false},"author":39,"featured_media":2976,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[518,39],"tags":[40],"class_list":["post-4281","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-italy-regulations","category-medical-devices-insights","tag-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.4 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Italy Simplifies Clinical Trials with New QA Document | RegASK<\/title>\n<meta name=\"description\" content=\"Italy publishes a QA document to facilitate the implementation of new clinical trial regulations. Stay informed with RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/italien-dokument-zur-qualitatssicherung-klinischer-studien\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Italy Publishes News Regarding Q&amp;A Document on Clinical Trials Facilitating Implementation of New Regulation\" \/>\n<meta property=\"og:description\" content=\"Italy publishes a QA document to facilitate the implementation of new clinical trial regulations. Stay informed with RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/italien-dokument-zur-qualitatssicherung-klinischer-studien\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-25T00:29:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-25T18:58:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png\" \/>\n\t<meta property=\"og:image:width\" content=\"689\" \/>\n\t<meta property=\"og:image:height\" content=\"626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"Italy Publishes News Regarding Q&amp;A Document on Clin&hellip;\",\"datePublished\":\"2023-05-25T00:29:06+00:00\",\"dateModified\":\"2024-10-25T18:58:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/\"},\"wordCount\":201,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Therapeutic-goods-medical-devices.png\",\"keywords\":[\"Latest Insights\"],\"articleSection\":[\"Italy\",\"Medical Devices\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/\",\"name\":\"Italy Simplifies Clinical Trials with New QA Document | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Therapeutic-goods-medical-devices.png\",\"datePublished\":\"2023-05-25T00:29:06+00:00\",\"dateModified\":\"2024-10-25T18:58:11+00:00\",\"description\":\"Italy publishes a QA document to facilitate the implementation of new clinical trial regulations. Stay informed with RegASK.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/italy-clinical-trials-qa-document\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Therapeutic-goods-medical-devices.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Therapeutic-goods-medical-devices.png\",\"width\":689,\"height\":626,\"caption\":\"fda\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Italien vereinfacht klinische Studien mit neuem QA-Dokument | RegASK","description":"Italien ver\u00f6ffentlicht ein QS-Dokument, um die Umsetzung neuer Vorschriften f\u00fcr klinische Studien zu erleichtern. Bleiben Sie mit RegASK auf dem Laufenden.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/italien-dokument-zur-qualitatssicherung-klinischer-studien\/","og_locale":"de_DE","og_type":"article","og_title":"Italy Publishes News Regarding Q&amp;A Document on Clinical Trials Facilitating Implementation of New Regulation","og_description":"Italy publishes a QA document to facilitate the implementation of new clinical trial regulations. Stay informed with RegASK.","og_url":"https:\/\/regask.com\/de\/italien-dokument-zur-qualitatssicherung-klinischer-studien\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2023-05-25T00:29:06+00:00","article_modified_time":"2024-10-25T18:58:11+00:00","og_image":[{"width":689,"height":626,"url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/italy-clinical-trials-qa-document\/#article","isPartOf":{"@id":"https:\/\/regask.com\/italy-clinical-trials-qa-document\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"Italy Publishes News Regarding Q&amp;A Document on Clin&hellip;","datePublished":"2023-05-25T00:29:06+00:00","dateModified":"2024-10-25T18:58:11+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/italy-clinical-trials-qa-document\/"},"wordCount":201,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/italy-clinical-trials-qa-document\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","keywords":["Latest Insights"],"articleSection":["Italy","Medical Devices"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/italy-clinical-trials-qa-document\/","url":"https:\/\/regask.com\/italy-clinical-trials-qa-document\/","name":"Italien vereinfacht klinische Studien mit neuem QA-Dokument | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/italy-clinical-trials-qa-document\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/italy-clinical-trials-qa-document\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","datePublished":"2023-05-25T00:29:06+00:00","dateModified":"2024-10-25T18:58:11+00:00","description":"Italien ver\u00f6ffentlicht ein QS-Dokument, um die Umsetzung neuer Vorschriften f\u00fcr klinische Studien zu erleichtern. Bleiben Sie mit RegASK auf dem Laufenden.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/italy-clinical-trials-qa-document\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/italy-clinical-trials-qa-document\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/09\/Therapeutic-goods-medical-devices.png","width":689,"height":626,"caption":"fda"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Agentic AI ist eine Plattform f\u00fcr regulatorische Analysen und Workflow-Orchestrierung in den Bereichen Life Sciences und Konsumg\u00fcter. RegASK kombiniert vertikale LLMs, eine Multiagenten-KI-Architektur und eine globale Community von \u00fcber 1.800 Fachexperten, um regulatorische Zukunftsprognosen, Wirkungsanalysen, die Automatisierung von Compliance-Workflows und auditfertige Ergebnisse in \u00fcber 160 L\u00e4ndern bereitzustellen.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/4281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=4281"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/4281\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/2976"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=4281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=4281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=4281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}